Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'INDUCED AGRANULOCYTOSIS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 237 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Reitzle, K; Warnke, A; Wewetzer, C; Muller, H
      Agranulocytosis in a schizophrenic child receiving clozapine therapy - clinical picture and therapy. a case report

      ZEITSCHRIFT FUR KINDER-UND JUGENDPSYCHIATRIE UND PSYCHOTHERAPIE
    2. Egan, TJ
      Quinoline antimalarials

      EXPERT OPINION ON THERAPEUTIC PATENTS
    3. Rubin, RL; Kretz-Rommel, A
      Phagocyte-mediated oxidation in idiosyncratic adverse drug reactions

      CURRENT OPINION IN HEMATOLOGY
    4. Palmblad, J; Papadaki, HA; Eliopoulos, G
      Acute and chronic neutropenias. What is new?

      JOURNAL OF INTERNAL MEDICINE
    5. Parent-Massin, D
      Relevance of clonogenic assays in hematotoxicology

      CELL BIOLOGY AND TOXICOLOGY
    6. Burns, MJ
      The pharmacology and toxicology of atypical antipsychotic agents

      JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY
    7. Rao, ML; Hiemke, C; Grasmader, K; Baumann, P
      Olanzapine: Pharmacology, pharmacokinetics and therapeutic drug monitoring

      FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE
    8. Pollmacher, T; Schuld, A; Kraus, T; Haack, M; Hinze-Selch, D
      On the clinical relevance of clozapine-triggered release of cytokines and soluble cytokine-receptors

      FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE
    9. Lee, JH; Lee, JH; Shin, YR; Lee, JS; Kim, WK; Chi, HS; Park, CJ; Lee, KH
      Spontaneous remission of aplastic anemia: a retrospective analysis

      HAEMATOLOGICA
    10. Breier, DV; Rendo, P; Gonzalez, J; Shilton, G; Stivel, M; Goldztein, S
      Massive plasmocytosis due to methimazole-induced bone marrow toxicity

      AMERICAN JOURNAL OF HEMATOLOGY
    11. Kraiem, Z; Newfield, RS
      Graves' disease in childhood

      JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM
    12. Coleman, MD
      Dapsone-mediated agranulocytosis: risks, possible mechanisms and prevention

      TOXICOLOGY
    13. Kodesh, A; Finkel, B; Lerner, AG; Kretzmer, G; Sigal, M
      Dose-dependent olanzapine-associated leukopenia: three case reports

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    14. Buchman, N; Strous, RD; Ulman, AM; Lerner, M; Kotler, M
      Olanzapine-induced leukopenia with human leukocyte antigen profiling

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    15. Mouithys-Mickalad, A; Kauffmann, JM; Petit, C; Bruhwyler, J; Liao, Y; Wikstrom, H; Damas, J; Delarge, J; Deby-Dupont, G; Geczy, J; Liegeois, JF
      Electrooxidation potential as a tool in the early screening for new safer clozapine-like analogues

      JOURNAL OF MEDICINAL CHEMISTRY
    16. Delarue, S; Girault, S; Ali, FD; Maes, L; Grellier, P; Sergheraert, C
      "One-pot" synthesis and antimalarial activity of formamidine derivatives of 4-anilinoquinoline

      CHEMICAL & PHARMACEUTICAL BULLETIN
    17. Maciejewski, JP; Follmann, D; Nakamura, R; Saunthararajah, Y; Rivera, CE; Simonis, T; Brown, KE; Barrett, JA; Young, NS
      Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome

      BLOOD
    18. Andres, E; Maloisel, F
      Antibiotic-induced agranulocytosis: A monocentric study of 21 cases

      ARCHIVES OF INTERNAL MEDICINE
    19. Pickar, D; Rubinow, K
      Pharmacogenomics of psychiatric disorders

      TRENDS IN PHARMACOLOGICAL SCIENCES
    20. Casey, DE; Bruhwyler, J; Delarge, J; Geczy, J; Liegeois, JF
      The behavioral effects of acute and chronic JL 13, a putative antipsychotic, in Cebus non-human primates

      PSYCHOPHARMACOLOGY
    21. Reznik, I; Mester, R
      Genetic factors in clozapine-induced agranulocytosis

      ISRAEL MEDICAL ASSOCIATION JOURNAL
    22. Silvestrini, C; Arcangeli, T; Biondi, M; Pancheri, P
      A second trial of clozapine in a case of granulocytopenia

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    23. Paradiso-Hardy, FL; Angelo, CM; Lanctot, KL; Cohen, EA
      Hematologic dyscrasia associated with ticlopidine therapy: evidence for causality

      CANADIAN MEDICAL ASSOCIATION JOURNAL
    24. Deliliers, GL
      Blood dyscrasias in clozapine-treated patients in Italy

      HAEMATOLOGICA
    25. Liegeois, JF; Zahid, N; Bruhwyler, J; Uetrecht, J
      Hypochlorous acid, a major oxidant produced by activated neutrophils, has low effect on two pyridobenzazepine derivatives, JL 3 and JL 13

      ARCHIV DER PHARMAZIE
    26. Aitchison, KJ; Jann, MW; Zhao, JH; Sakai, T; Zaher, H; Wolff, K; Collier, DA; Kerwin, RW; Gonzalez, FJ
      Clozapine pharmacokinetics and pharmacodynamics studied with CYP1A2-null mice

      JOURNAL OF PSYCHOPHARMACOLOGY
    27. Andres, E; Maloisel, F; Kurtz, JE; Vinzio, S; Sibilia, J; Schlienger, JL; Dufour, P
      Are hematopoietic growth factors useful in the management of drug-induced agranulocytosis?

      REVUE DE MEDECINE INTERNE
    28. Felber, W; Naumann, R; Schuler, U; Fulle, M; Reuster, T; Garcia, K; Heilemann, H
      Are there genetic determinants of olanzapine-induced agranulocytosis?

      PHARMACOPSYCHIATRY
    29. Dettling, M
      Are there genetic determinants of olanzapine-induced agranulocytosis? Reply of the authors

      PHARMACOPSYCHIATRY
    30. Miller, DD
      Review and management of clozapine side effects

      JOURNAL OF CLINICAL PSYCHIATRY
    31. Naisbitt, DJ; Gordon, SF; Pirmohamed, M; Park, BK
      Immunological principles of adverse drug reactions - The initiation and propagation of immune responses elicited by drug treatment

      DRUG SAFETY
    32. Munshi, HG; Montgomery, RB
      Severe neutropenia: a diagnostic approach

      WESTERN JOURNAL OF MEDICINE
    33. Lai, WG; Gardner, I; Zahid, N; Uetrecht, JP
      Bioactivation and covalent binding of hydroxyfluperlapine in human neutrophils: Implications for fluperlapine-induced agranulocytosis

      DRUG METABOLISM AND DISPOSITION
    34. Sajatovic, M
      Clozapine for elderly patients

      PSYCHIATRIC ANNALS
    35. Ohtsu, F; Yano, R; Inagaki, K; Sakakibara, J
      Estimation of adverse drug reactions by the evaluation scores of subjective symptoms (complaints) and background of patients. III. Drug-induced leucopenia

      YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN
    36. Williams, DP; Pirmohamed, M; Naisbitt, DJ; Uetrecht, JP; Park, BK
      Induction of metabolism-dependent and -independent neutrophil apoptosis byclozapine

      MOLECULAR PHARMACOLOGY
    37. Pollmacher, T; Haack, M; Schuld, A; Kraus, T; Hinze-Selch, D
      Effects of antipsychotic drugs on cytokine networks

      JOURNAL OF PSYCHIATRIC RESEARCH
    38. Mylonakis, E; Akhtar, MS; Lopez, F; Hussain, SI; Chen, JL; Koutkia, P; Lamberton, P; Schiffman, FJ
      Resolution of drug-induced agranulocytosis

      GERIATRICS
    39. Jauss, M; Pantel, J; Werle, E; Schroder, J
      G-CSF plasma levels in clozapine-induced neutropenia

      BIOLOGICAL PSYCHIATRY
    40. Schuld, A; Kraus, T; Hinze-Selch, D; Haack, M; Pollmacher, T
      Granulocyte colony-stimulating factor plasma levels during clozapine- and olanzapine-induced granulocytopenia

      ACTA PSYCHIATRICA SCANDINAVICA
    41. Hinze-Selch, D; Deuschle, M; Weber, B; Heuser, I; Pollmacher, T
      Effect of coadministration of clozapine and fluvoxamine versus clozapine monotherapy on blood cell counts, plasma levels of cytokines and body weight

      PSYCHOPHARMACOLOGY
    42. Sheng, WH; Hung, CC; Chen, YC; Fang, CT; Hsieh, SM; Chang, SC; Hsieh, WC
      Antithyroid-drug-induced agranulocytosis complicated by life-threatening infections

      QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS
    43. Altunbas, H; Yazicioglu, G; Balci, MK; Karayalcin, U; Undar, L
      The use of recombinant human G-CSF in the treatment of propylthiouracil-induced agranulocytosis

      INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    44. Vial, T; Gallant, C; Choquet-Kastylevsky, G; Descotes, J
      Treatment of drug-induced agranulocytosis with haematopoietic growth factors - A review of the clinical experience

      BIODRUGS
    45. Hu, RJ; Malhotra, AK; Pickar, D
      Predicting response to clozapine - Status of current research

      CNS DRUGS
    46. Cooper, DS
      The side effects of antithyroid drugs

      ENDOCRINOLOGIST
    47. Fukata, S; Kuma, K; Sugawara, M
      Granulocyte colony-stimulating factor (G-CSF) does not improve recovery from antithyroid drug-induced agranulocytosis: A prospective study

      THYROID
    48. Uetrecht, JP
      New concepts in immunology relevant to idiosyncratic drug reactions: The "danger hypothesis" and innate immune system

      CHEMICAL RESEARCH IN TOXICOLOGY
    49. Jegouzo, A; Gressier, B; Frimat, B; Brunet, C; Dine, T; Luyckx, M; Kouach, M; Cazin, M; Cazin, JC
      Comparative oxidation of loxapine and clozapine by human neutrophils

      FUNDAMENTAL & CLINICAL PHARMACOLOGY
    50. Guest, I; Uetrecht, J
      Drugs that induce neutropenia/agranulocytosis may target specific components of the stromal cell extracellular matrix

      MEDICAL HYPOTHESES
    51. Chan, YC; Pariser, SF; Neufeld, G
      Atypical antipsychotics in older adults

      PHARMACOTHERAPY
    52. Beauchesne, MF; Shalansky, SJ
      Nonchemotherapy drug-induced agranulocytosis: A review of 118 patients treated with colony-stimulating factors

      PHARMACOTHERAPY
    53. Steinwachs, A; Grohmann, R; Pedrosa, F; Ruther, E; Schwerdtner, I
      Two cases of olanzapine-induced reversible neutropenia

      PHARMACOPSYCHIATRY
    54. Dettling, M; Cascorbi, I; Hellweg, R; Deicke, U; Weise, L; Muller-Oerlinghausen, B
      Genetic determinants of drug-induced agranulocytosis: Potential risk of olanzapine?

      PHARMACOPSYCHIATRY
    55. Swartz, JR; Ananth, J; Smith, MW; Burgoyne, KS; Gadasally, R; Arai, Y
      Olanzapine treatment after clozapine-induced granulocytopenia in 3 patients

      JOURNAL OF CLINICAL PSYCHIATRY
    56. Howanitz, E; Pardo, M; Smelson, DA; Engelhart, C; Eisenstein, N; Losonczy, MF
      The efficacy and safety of clozapine versus chlorpromazine in geriatric schizophrenia

      JOURNAL OF CLINICAL PSYCHIATRY
    57. Alphs, LD; Anand, R
      Clozapine: The commitment to patient safety

      JOURNAL OF CLINICAL PSYCHIATRY
    58. Oyewumi, KL
      Does lithium have a role in the prevention and management of clozapine-induced granulocytopenia?

      PSYCHIATRIC ANNALS
    59. Meyer, O; Gaedicke, G; Salama, A
      Demonstration of drug-dependent antibodies in two patients with neutrophenia and successful treatment with granulocyte-colony-stimulating factor

      TRANSFUSION
    60. Lorenz, M; Evering, WE; Provencher, A; Blue, JT; Lewis, HB; Hazelette, JR; Rajagopalan, P; Meunier, PC; Car, BD
      Atypical antipsychotic-induced neutropenia in dogs

      TOXICOLOGY AND APPLIED PHARMACOLOGY
    61. Winfred, RI; Nanda, S; Horvath, G; Elnicki, M
      Captopril-induced toxic epidermal necrolysis and agranulocytosis successfully treated with granulocyte colony-stimulating factor

      SOUTHERN MEDICAL JOURNAL
    62. Grube, M; Kurzweg, A
      Leucopenia under butyrophenones - successful treatment of severe schizophrenic psychoses by giving benperidol intermittent every other day

      NERVENARZT
    63. Raynes, KJ; Stocks, PA; O'Neill, PM; Park, BK; Ward, SA
      New 4-aminoquinoline mannich base antimalarials. 1. Effect of an alkyl substituent in the 5 '-position of the 4 '-hydroxyanilino side chain

      JOURNAL OF MEDICINAL CHEMISTRY
    64. Barnes, TRE; McPhillips, MA
      Critical analysis and comparison of the side-effect and safety profiles ofthe new antipsychotics

      BRITISH JOURNAL OF PSYCHIATRY
    65. Marsh, JCW; Chowdry, J; Parry-Jones, N; Ellis, SW; Muir, KR; Gordon-Smith, EC; Tucker, GT
      Study of the association between cytochromes P450 2D6 and 2E1 genotypes and the risk of drug and chemical induced idiosyncratic aplastic anaemia

      BRITISH JOURNAL OF HAEMATOLOGY
    66. Weiss, M; Moldawer, LL; Schneider, EM
      Granulocyte colony-stimulating factor to prevent the progression of systemic nonresponsiveness in systemic inflammatory response syndrome and sepsis

      BLOOD
    67. Liegeois, JF; Bruhwyler, J; Petit, C; Damas, J; Delarge, J; Geczy, J; Kauffmann, JM; Lamy, M; Meltzer, H; Mouithys-Mickalad, A
      Oxidation sensitivity may be a useful tool for the detection of the hematotoxic potential of newly developed molecules: Application to antipsychotic drugs

      ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
    68. MORRIS S; HOGAN T; MCGUIRE A
      THE COST-EFFECTIVENESS OF CLOZAPINE - A SURVEY OF THE LITERATURE

      Clinical drug investigation
    69. MEZQUITA P; LUNA V; MUNOZTORRES M; TORRESVELA E; LOPEZRODRIGUEZ F; CALLEJAS JL; ESCOBARJIMENEZ F
      METHIMAZOLE-INDUCED APLASTIC-ANEMIA IN 3RD EXPOSURE - SUCCESSFUL TREATMENT WITH RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR

      Thyroid
    70. NAVAS F; TANG FLM; SCHALLER LT; NORMAN MH
      ANALOGS OF THE POTENTIAL ANTIPSYCHOTIC AGENT 1192U90 - AMIDE MODIFICATIONS

      Bioorganic & medicinal chemistry
    71. PARK BE; PIRMOHAMED M; KITTERINGHAM NR
      ROLE OF DRUG DISPOSITION IN DRUG HYPERSENSITIVITY - A CHEMICAL, MOLECULAR, AND CLINICAL PERSPECTIVE

      Chemical research in toxicology
    72. Naisbitt, DJ; Williams, DP; O'Neill, PM; Maggs, JL; Willock, DJ; Pirmohamed, M; Park, BK
      Metabolism-dependent neutrophil cytotoxicity of amodiaquine: A comparison with pyronaridine and related antimalarial drugs

      CHEMICAL RESEARCH IN TOXICOLOGY
    73. YOUNG CD; MELTZER HY; DEUTCH AY
      EFFECTS OF DESMETHYLCLOZAPINE ON FOS PROTEIN EXPRESSION IN THE FOREBRAIN - IN-VIVO BIOLOGICAL-ACTIVITY OF THE CLOZAPINE METABOLITE

      Neuropsychopharmacology
    74. COOPER DS
      ANTITHYROID DRUGS FOR THE TREATMENT OF HYPERTHYROIDISM CAUSED BY GRAVES-DISEASE

      Endocrinology and metabolism clinics of North America
    75. YOUNG CR; BOWERS MB; MAZURE CM
      MANAGEMENT OF THE ADVERSE-EFFECTS OF CLOZAPINE

      Schizophrenia bulletin
    76. DELILIERS GL; SERVIDA F; LAMORTE G; QUIRICI N; SOLIGO D
      IN-VITRO EFFECT OF CLOZAPINE ON HEMATOPOIETIC PROGENITOR CELLS

      Haematologica
    77. VANDERKLAUW MM; WILSON JHP; STRICKER BHC
      DRUG-ASSOCIATED AGRANULOCYTOSIS - 20 YEARS OF REPORTING IN THE NETHERLANDS (1974-1994)

      American journal of hematology
    78. Murphy, PT; Casey, MC
      Sulphasalazine induced agranulocytosis revisited

      IRISH MEDICAL JOURNAL
    79. ROELOFFZEN WWH; VERHAEGH JJ; VANPOELGEEST AE; GANSEVOORT RT
      FEVER OR A SOAR THROAT AFTER START OF ANTITHYROIDAL DRUGS - A MEDICALEMERGENCY

      Netherlands journal of medicine
    80. LEECH NJ; DAYAN CM
      CONTROVERSIES IN THE MANAGEMENT OF GRAVES-DISEASE

      Clinical endocrinology
    81. IITAKA M; NOH JY; KITAHAMA S; FUKASAWA N; MIURA S; KAWAKAMI Y; KAWASAKI S; YAMANAKA K; ISHII J; KATAYAMA S; ITO K
      ELEVATED SERUM GRANULOCYTE-COLONY-STIMULATING FACTOR LEVELS IN PATIENTS WITH GRAVES-DISEASE

      Clinical endocrinology
    82. CASTANHEIRA D; MARZELLA M; SKIRVIN JA
      ADMINISTRATION OF FILGRASTIM IN 2 PATIENTS WITH DRUG-INDUCED AGRANULOCYTOSIS

      Pharmacotherapy
    83. SILVERSTONE PH
      PREVENTION OF CLOZAPINE-INDUCED NEUTROPENIA BY PRETREATMENT WITH LITHIUM

      Journal of clinical psychopharmacology
    84. KING DJ; WAGER E
      HEMATOLOGICAL SAFETY OF ANTIPSYCHOTIC-DRUGS

      JOURNAL OF PSYCHOPHARMACOLOGY
    85. Snowden, JA; Biggs, JC; Milliken, ST; Fuller, A; Staniforth, D; Passuello, F; Renwick, J; Brooks, PM
      A randomised, blinded, placebo-controlled, dose escalation study of the tolerability and efficacy of filgrastim for haemopoietic stem cell mobilisation in patients with severe active rheumatoid arthritis

      BONE MARROW TRANSPLANTATION
    86. FINKEL B; LERNER A; OYFFE I; RUDINSKI D; SIGAL M; WEIZMAN A
      OLANZAPINE TREATMENT IN PATIENTS WITH TYPICAL AND ATYPICAL NEUROLEPTIC-ASSOCIATED AGRANULOCYTOSIS

      International clinical psychopharmacology
    87. BLIER P; SLATER S; MEASHAM T; KOCH M; WIVIOTT G
      LITHIUM AND CLOZAPINE-INDUCED NEUTROPENIA AGRANULOCYTOSIS/

      International clinical psychopharmacology
    88. Verbeeck, WJC; Berk, M
      Clozapine associated neutropenia and cytomegalovirus colitis

      PHARMACOPSYCHIATRY
    89. HONIGFELD G; ARELLANO F; SETHI J; BIANCHINI A; SCHEIN J
      REDUCING CLOZAPINE-RELATED MORBIDITY AND MORTALITY - 5 YEARS OF EXPERIENCE WITH THE CLOZARIL NATIONAL REGISTRY

      The Journal of clinical psychiatry
    90. LIEBERMAN JA
      MAXIMIZING CLOZAPINE THERAPY - MANAGING SIDE-EFFECTS

      The Journal of clinical psychiatry
    91. KRISHNAN K; KRISHNASWAMY G
      SEVERE BACTRIM-INDUCED NEUTROPENIA WITH REVERSAL OF CD4(+) CD8(+) LYMPHOCYTE RATIO - RESPONSE TO RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR (R-METHUG-CSF)/

      Clinical and laboratory haematology
    92. PARCHMENT RE
      ALTERNATIVE TESTING SYSTEMS FOR EVALUATING NONCARCINOGENIC, HEMATOLOGIC TOXICITY

      Environmental health perspectives
    93. ANDRES E; KURTZ JE; OFFNER C; GRUNENBERGER F; WEBER JC; KALTENBACH G; NEYROLLES N; MALOISEL F
      DRUG-INDUCED AGRANULOCYTOSIS - EXPERIENCE AT THE STRASBOURG-TEACHING-HOSPITAL

      La Semaine des hopitaux de Paris
    94. FANG J; COUTTS RT; MCKENNA KF; BAKER GB
      ELUCIDATION OF INDIVIDUAL CYTOCHROME-P450 ENZYMES INVOLVED IN THE METABOLISM OF CLOZAPINE

      Naunyn-Schmiedeberg's archives of pharmacology
    95. GARDNER I; ZAHID N; MACCRIMMON D; UETRECHT JP
      A COMPARISON OF THE OXIDATION OF CLOZAPINE AND OLANZAPINE TO REACTIVEMETABOLITES AND THE TOXICITY OF THESE METABOLITES TO HUMAN-LEUKOCYTES

      Molecular pharmacology
    96. GARDNER I; LEEDER JS; CHIN T; ZAHID N; UETRECHT JP
      A COMPARISON OF THE COVALENT BINDING OF CLOZAPINE AND OLANZAPINE TO HUMAN NEUTROPHILS IN-VITRO AND IN-VIVO

      Molecular pharmacology
    97. SPERNERUNTERWEGER B; CZEIPEK I; GAGGL S; GEISSLER D; SPIEL G; FLEISCHHACKER WW
      TREATMENT OF SEVERE CLOZAPINE-INDUCED NEUTROPENIA WITH GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) - REMISSION DESPITE CONTINUOUS TREATMENT WITH CLOZAPINE

      British Journal of Psychiatry
    98. YI CY; TAN IKS
      RESCUE FROM NEUTROPENIC FEVER AND A BAMBOO POLE

      Anaesthesia
    99. CLAVIJO OP; DELGADO JC; AWDEH ZL; FICI D; TURBAY D; ALPER CA; TRUEDSSON L; YUNIS EJ
      HLA-CW ALLELES ASSOCIATED WITH HLA EXTENDED HAPLOTYPES AND C2 DEFICIENCY

      Tissue antigens
    100. MAURI MC; RUDELLI R; BRAVIN S; GIANETTI S; GIULIANI E; GUERRINI A; ORLANDI R; INVERNIZZI G
      CLOZAPINE METABOLISM RATE AS A POSSIBLE INDEX OF DRUG-INDUCED GRANULOCYTOPENIA

      Psychopharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 09/12/19 alle ore 14:25:52